- Home
- SMSI vs CARA Comparison
SMSI vs CARA Comparison
Compare SMSI & CARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- CARA
- Stock Information
- Founded
- SMSI 1982
- CARA 2004
- Country
- SMSI United States
- CARA United States
- Employees
- SMSI N/A
- CARA N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- CARA Biotechnology: Pharmaceutical Preparations
- Sector
- SMSI Technology
- CARA Health Care
- Exchange
- SMSI Nasdaq
- CARA Nasdaq
- Market Cap
- SMSI 16.2M
- CARA 16.7M
- IPO Year
- SMSI 1995
- CARA 2014
- Fundamental
- Price
- SMSI $1.13
- CARA $4.65
- Analyst Decision
- SMSI Strong Buy
- CARA Hold
- Analyst Count
- SMSI 1
- CARA 3
- Target Price
- SMSI $5.00
- CARA $12.00
- AVG Volume (30 Days)
- SMSI 732.1K
- CARA 331.3K
- Earning Date
- SMSI 02-20-2025
- CARA 03-03-2025
- Dividend Yield
- SMSI N/A
- CARA N/A
- EPS Growth
- SMSI N/A
- CARA N/A
- EPS
- SMSI N/A
- CARA N/A
- Revenue
- SMSI $24,178,000.00
- CARA $8,686,000.00
- Revenue This Year
- SMSI N/A
- CARA N/A
- Revenue Next Year
- SMSI $53.43
- CARA N/A
- P/E Ratio
- SMSI N/A
- CARA N/A
- Revenue Growth
- SMSI N/A
- CARA N/A
- 52 Week Low
- SMSI $0.52
- CARA $2.71
- 52 Week High
- SMSI $7.52
- CARA $13.80
- Technical
- Relative Strength Index (RSI)
- SMSI 47.52
- CARA 52.14
- Support Level
- SMSI $1.05
- CARA $4.32
- Resistance Level
- SMSI $1.95
- CARA $4.92
- Average True Range (ATR)
- SMSI 0.23
- CARA 0.66
- MACD
- SMSI -0.06
- CARA -0.10
- Stochastic Oscillator
- SMSI 8.89
- CARA 28.75
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. It offers multi-platform, modular solutions such as SafePath; CommSuite; and ViewSpot. The company's only reportable segment is Wireless. Its Wireless segment sells to large wireless carriers, cable operators, and OEMs.
About CARA Cara Therapeutics Inc.
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.